Akebia Therapeutics, Inc.: 8-K Report
8-K...…
Börse:
0,387$
-0,57%
Echtzeit-Aktienkurs Akebia Therapeutics Inc.
Bid:
0,367$
Ask:
0,407$
Nachrichten zur Akebia Therapeutics Inc. Aktie
Another Look At Akebia Therapeutics
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Insiderhandel: SVP, Chief Medical Officer verkauft Aktien von Akebia Therapeutics im Wert von 2.949$
Burke, Steven Keith - Vorstand - Tag der Transaktion: 2021-08-31...…
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass., Sept. 1, 2021 /PRNewswire/ -- Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better…
Akebia Therapeutics, Inc.: 8-K Report
8-K...…
Akebia Therapeutics, Inc.: 10-Q Report
10-Q...…
Why Akebia Therapeutics Stock Is Soaring Today
Investors liked what they heard in the companys Q2 update....…
Akebia Therapeutics, Inc. (AKBA) CEO John Butler on Q2 2021 Results - Earnings Call Transcript
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Akebia Therapeutics (AKBA) Reports Q2 Loss, Misses Revenue Estimates
Akebia Therapeutics (AKBA) delivered earnings and revenue surprises of -70.00% and -11.93%, respectively, for the quarter ended June 2021. Do…
Thinking about buying stock in Ion Geophysical, Moneygram International, Akebia Therapeutics, iBio, or Exela Technologies?
NEW YORK, July 16, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for IO, MGI, AKBA, IBIO, and XELA. To…
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass., July 1, 2021 /PRNewswire/ -- Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better…
Akebia wins $40M Department of Veterans Affairs contract
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Cyclerion Out-Licenses Praliciguat to Akebia, Announces $18M Capital Raise
read more...…
Cyclerion inks global licensing agreement with Akebia for as much as $585M
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Cyclerion Therapeutics Announces Global Licensing Agreement with Akebia Therapeutics for Praliciguat
Cyclerion eligible to receive up to $585 million in potential future development and commercial milestone payments, and tiered sales-based royalties...…
Akebia Therapeutics, Inc.: 8-K Report
8-K...…
Thinking about buying stock in Akebia Therapeutics, BlackBerry, Seelos Therapeutics, Canopy Growth Corp, or Aqua Metals?
NEW YORK, June 1, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AKBA, BB, SEEL, CGC, and AQMS. To…
Implied Volatility Surging for Akebia Therapeutics (AKBA) Stock Options
Investors need to pay close attention to Akebia Therapeutics (AKBA) stock based on the movements in the options market lately....…
Akebia: Pessimism On Vadadustat Approval Justified, But Risky Bull Case Can Be Made
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Akebia Therapeutics, Inc. (AKBA) CEO John Butler on Q1 2021 Results - Earnings Call Transcript
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Akebia Therapeutics (AKBA) Reports Q1 Loss, Tops Revenue Estimates
Akebia Therapeutics (AKBA) delivered earnings and revenue surprises of -36.36% and 19.43%, respectively, for the quarter ended March 2021. Do…
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass., May 4, 2021 /PRNewswire/ -- Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better…
New England Journal of Medicine Publishes Results of Global Phase 3 Clinical Program of Vadadustat for the Treatment of Anemia Due to Chronic Kidney Disease
CAMBRIDGE, Mass., April 28, 2021 /PRNewswire/ -- Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better…
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Akebia Therapeutics, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors
NEW YORK, April 26, 2021 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing…
BioStock studio: Saniona’s CFO on his visions for the company
Sanionas CFO Jason Amello recently linked up to the BioStock Studio at Medicon Village in Lund from Boston for an…
Insiderhandel: SVP, CCO verkauft Aktien von Akebia Therapeutics im Wert von 3.237$
Faulkingham, Dell - Vorstand - Tag der Transaktion: 2021-04-01...…
Insiderhandel: CEO and President verkauft Aktien von Akebia Therapeutics im Wert von 13.971$
Butler, John P. - Vorstand - Tag der Transaktion: 2021-04-01...…
Insiderhandel: SVP, Chief Medical Officer verkauft Aktien von Akebia Therapeutics im Wert von 3.675$
Burke, Steven Keith - Vorstand - Tag der Transaktion: 2021-04-01...…
Insiderhandel: SVP, CFO and Treasurer verkauft Aktien von Akebia Therapeutics im Wert von 2.686$
Spellman, David A. - Vorstand - Tag der Transaktion: 2021-04-01...…
Insiderhandel: SVP, Chief Legal Officer verkauft Aktien von Akebia Therapeutics im Wert von 3.604$
Hadas, Nicole R. - Vorstand - Tag der Transaktion: 2021-04-01...…
Insiderhandel: SVP, Chief Operating Officer verkauft Aktien von Akebia Therapeutics im Wert von 4.117$
Dahan, Michel - Vorstand - Tag der Transaktion: 2021-04-01...…
Akebia (AKBA) Files NDA for Vadadustat for Anemia Due to CKD
Akebia (AKBA) submits new drug application for vadadustat to treat anemia due to chronic kidney disease in adult patients who…
Akebia files marketing application for Vadadustat in anemia due to CKD
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Akebia announces Japanese approval for expanded use of Riona
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Akebia Therapeutics (AKBA) Presents At H.C. Wainwright Global Life Sciences Virtual Conference - Slideshow
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Akebia Therapeutics Celebrates World Kidney Day and National Kidney Month
CAMBRIDGE, Mass. , March 11, 2021 /PRNewswire/ -- Akebia Therapeutics, Inc. …
Insiderhandel: CEO and President verkauft Aktien von Akebia Therapeutics im Wert von 339.542$
Butler, John P. - Vorstand - Tag der Transaktion: 2021-03-01...…
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass. , March 2, 2021 /PRNewswire/ -- Akebia Therapeutics, Inc. …
Akebia Therapeutics to Present at H.C. Wainwright Global Life Sciences Conference
CAMBRIDGE, Mass. , March 2, 2021 /PRNewswire/ -- Akebia Therapeutics, Inc. …
Akebia Therapeutics, Inc. (AKBA) CEO John Butler on Q4 2020 Results - Earnings Call Transcript
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Why Akebia Therapeutics Stock Is Plunging Today
Investors were not impressed with the drugmakers latest quarterly update....…
Akebia Reports Fourth Quarter and Full-Year 2020 Financial Results and Provides Business Updates
CAMBRIDGE, Mass. , Feb. 25, 2021 /PRNewswire/ -- …
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass. , Feb. 2, 2021 /PRNewswire/ -- Akebia Therapeutics, Inc. …
Return On Capital Employed Overview: Akebia Therapeutics
During Q3, Akebia Therapeutics (NASDAQ:AKBA) brought in sales totaling $59.99 million. However, earnings decreased 66.58%, resulting in a loss of…
Akebia Therapeutics to Present at H.C. Wainwright Bioconnect 2021 Conference
Um den gesamten Artikel unter barchart.com zu lesen, klicken Sie bitte auf die Überschrift...…
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass. , Jan. 5, 2021 /PRNewswire/ -- Akebia Therapeutics, Inc. …
Akebia Therapeutics to Present at 39th Annual J.P. Morgan Healthcare Conference
CAMBRIDGE, Mass. , Jan. 4, 2021 /PRNewswire/ -- Akebia Therapeutics, Inc. …
Implied Volatility Surging for Akebia Therapeutics (AKBA) Stock Options
Investors need to pay close attention to Akebia Therapeutics (AKBA) stock based on the movements in the options market lately....…
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass. , Dec. 2, 2020 /PRNewswire/ -- Akebia Therapeutics, Inc. …
The Play On Akebia Now
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…